Effect of Intake of Allium Cepa L. Peel Heated Water Extract on Immunity Enhancement
- Conditions
- Upper Respiratory Infection
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Allium Cepa L. Peel Heated Water Extract
- Registration Number
- NCT05666752
- Lead Sponsor
- Hanyang University
- Brief Summary
This study was conducted to investigate the effects of daily supplementation of Allium Cepa L. Peel Heated Water Extract on Immunity Enhancement
- Detailed Description
This study was a 8 weeks, randomized, double-blind, placebo-controlled human trial. 40 subjects were randomly divided into Allium Cepa L. Peel Heated Water Extract or a placebo group. Immunity Enhancement profiles before and after the intervention.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 80
- Age 19-75 years
- Symptoms of upper respiratory infection at least once within past 12 months
- Cardio-cerebrovascular, endocrine, immune, respiratory, musculoskeletal, inflammatory, hematologic, tumorigenic, gastrointestinal diseases, etc.
- Vaccination within past 2 months
- BMI < 18.5 kg/m2 or 35 kg/m2 ≤ BMI
- Immunity enhancement agents within past one months
- Allergic or hypersensitive to any of the ingredients in the test products
- Antipsychotic drugs therapy within past 3 months
- History of alcoholism or drug abuse
- Participation in any other clinical trials within past 3 months
- Pregnant or lactating women
- Judged ineligible to participate in the trial by the principal investigator
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo Placebo 4 capsules/day after meal(1,200 mg/day) for 8 weeks Allium Cepa L. Peel Heated Water Extract Allium Cepa L. Peel Heated Water Extract 4 capsules/day after meal(1,200 mg/day) for 8 weeks
- Primary Outcome Measures
Name Time Method Changes of Natural killer(NK) cell activity At week 0 and week 8 Changes of Natural killer(NK) cell activity will be assessed before and after the intervention.
PBMCs were isolated by density gradient separation, resuspended in phosphate-buffered saline, and determined using trypan blue solution. Natural killer(NK) cell activity was calculated from the results of nonradioactive cytotoxicity assay kits. Effector cells (PBMCs) were seeded in 96-well plates, with 50 ul of target cells (K562), incubated for 4 hours. cytotoxicity was calculated using the following formula: \[(experimental-effector spontaneous-target spontaneous)/(target maximum-target spontaneous)\]\*100.
- Secondary Outcome Measures
Name Time Method Changes of Cytokines(INF-gamma, Interleukin(IL)-2, IL-6, IL-12, Tumor Necrosis Factor(TNF)-alpha, and IL-1beta) At week 0 and week 8 Changes of Cytokines(INF-gamma, IL-2, IL-6, IL-12, TNF-alpha, and IL-1beta) will be assessed before and after the intervention.
the serum levels of cytokines, including INF-gamma, IL-2, IL-6, IL-12, TNF-alpha, and IL-1beta will be measured.Changes of Wisconsin Upper Respiratory Symptom Survey-21 At week 0 and week 4 and week 8 Changes of Wisconsin Upper Respiratory Symptom Survey-21 will be assessed before and after the intervention
Trial Locations
- Locations (1)
Hanyang University
🇰🇷Seoul, Korea, Republic of